CONNECT WITH US
Tech

Tech

CureBay raises Rs 100 Cr in Pre-Series C round led by IvyCap Ventures

YourStory - Demo logo

Published on

Add as a preferred source on Google
CureBay raises Rs 100 Cr in Pre-Series C round led by IvyCap Ventures

Rural healthcare platform CureBay has raised Rs 100 crore in a Pre-Series C funding round led by IvyCap Ventures.

The round includes Rs 69 crore in equity from IvyCap Ventures and existing investors, along with over Rs 30 crore in debt from Trifecta Capital, Alteria Capital and VentureSoul Partners.

CureBay said it will use the funds to expand its operations across India, strengthen its healthcare delivery network, and develop its technology and AI capabilities. These include its Intelligence Layer, which is designed to support patient screening, health insights and clinical decision-making.

Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra and Sanjay Swain, CureBay operates a technology-enabled rural healthcare network combining physical clinics with digital services. Its model includes IoT-enabled clinics, a network of Swasthya Mitras, a connected digital platform, AI-powered screening and risk alerts, a 24/7 command centre, and CureBay Kavach.

The company operates more than 250 technology-enabled clinics across seven states. It said it has served over 17 lakh patients and conducts more than 400 health camps each month.

“Rural Bharat doesn’t need another app; it needs a system that works end to end, from the Swasthya Mitra at the doorstep to the specialist in the city. This capital lets us take that operating system to more states and make our AI do the heavy lifting, so that every family gets the right care at the right time, close to home,” said Priyadarshi Mohapatra, Founder and CEO, CureBay.

“CureBay’s ability to combine technology with a strong on-ground healthcare network makes its model particularly compelling.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.